WorldHealth
DR Congo begins Ebola vaccine trial as Bundibugyo outbreak kills 3,639
Health workers in the Democratic Republic of Congo launched a test vaccination programme on September 20, 2026, to assess whether the Ervebo vaccine, developed for a different Ebola strain, is effective against the Bundibugyo strain. The WHO- and MSF-backed study plans to vaccinate 20,000 frontline health personnel in Ituri and North-Kivu provinces over up to a year. The outbreak has killed 3,639 of 7,541 confirmed cases, a 48.3% fatality rate.
The Democratic Republic of Congo has begun testing an Ebola vaccine in areas hit by a deadly outbreak, with health workers launching a test vaccination programme on September 20, 2026.
The effort, backed by the World Health Organization and Doctors Without Borders (MSF), will give the Ervebo vaccine to 20,000 frontline health personnel in Ituri and North-Kivu provinces. The study is scheduled to last up to a year and aims to determine whether a vaccine designed for a different Ebola strain can work against the current one.
The outbreak is caused by the Bundibugyo strain, for which no approved vaccine currently exists. According to the latest figures from Congolese authorities, it has killed 3,639 people out of 7,541 confirmed cases, a fatality rate of 48.3%.
- Congo
- Ebola
- Ebola vaccine
- Ebola vaccine dr congo
- Ebola outbreak
From
WorldHealth
DR Congo begins Ebola vaccine trial as Bundibugyo outbreak kills 3,639
Health workers in the Democratic Republic of Congo launched a test vaccination programme on September 20, 2026, to assess whether the Ervebo vaccine, developed for a different Ebola strain, is effective against the Bundibugyo strain. The WHO- and MSF-backed study plans to vaccinate 20,000 frontline health personnel in Ituri and North-Kivu provinces over up to a year. The outbreak has killed 3,639 of 7,541 confirmed cases, a 48.3% fatality rate.
The Democratic Republic of Congo has begun testing an Ebola vaccine in areas hit by a deadly outbreak, with health workers launching a test vaccination programme on September 20, 2026.
The effort, backed by the World Health Organization and Doctors Without Borders (MSF), will give the Ervebo vaccine to 20,000 frontline health personnel in Ituri and North-Kivu provinces. The study is scheduled to last up to a year and aims to determine whether a vaccine designed for a different Ebola strain can work against the current one.
The outbreak is caused by the Bundibugyo strain, for which no approved vaccine currently exists. According to the latest figures from Congolese authorities, it has killed 3,639 people out of 7,541 confirmed cases, a fatality rate of 48.3%.
- Congo
- Ebola
- Ebola vaccine
- Ebola vaccine dr congo
- Ebola outbreak
From